Response to mivacurium in a patient compound heterozygous for a novel and a known silent mutation in the butyrylcholinesterase gene: Genotyping by sequencing

Anesthesiology

Volumn 95, Issue 3, 2001, Pages 600-606

  Gätke, Mona R ^a,b   Østergaard, Doris ^c   Bundgaard, Jens R ^b   Varin, France ^d   Viby Mogensen, Jørgen ^a  

^a Danish Cholinesterase Research Unit   (Denmark)

^b Rigshospitalet   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE; MIVACURIUM;

ADULT; ANESTHESIA MECHANISM; ARTICLE; CASE REPORT; CIS TRANS ISOMERISM; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG HALF LIFE; GENE MUTATION; GENOTYPE; HUMAN; MALE; MYOGRAPHY; NEUROMUSCULAR BLOCKING; NUCLEOTIDE SEQUENCE; PEDIGREE; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; SILENT GENE;

EID: 0034843419     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200109000-00010     Document Type: Article

References (33)

1. Pesticides and susceptible populations: People with butyrylcholinesterase genetic variants may be at risk
2. Mivacurium-induced neuromuscular blockade in patients with atypical plasma cholinesterase
3. Prolonged neuromuscular block following mivacurium
4. Mivacurium sensitivity in a patient heterozygous for the atypical and silent genes for plasma cholinesterase
5. Prolonged neuromuscular block after mivacurium
6. Prolonged neuromuscular block from mivacurium in two patients with cholinesterase deficiency
7. Prolonged paralysis after a test dose of mivacurium in a patient with atypical serum cholinesterase
8. Markedly prolonged paralysis after mivacurium in a patient apparently heterozygous for the atypical and usual pseudocholinesterase alleles by conventional biochemical testing
9. Prolonged neuromuscular blockade with mivacurium in a newborn
10. Prolonged mivacurium neuromuscular block in children
11. Prolonged neuromuscular block associated with mivacurium
12. Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade in phenotypically normal patients
13. Identification of human plasma cholinesterase variants in 6,688 individuals using biochemical analysis
14. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents
15. High performance liquid chromatographic assay for cisatracurium and its metabolites in human urine
16. The cloned butyrylcholinesterase (BCHE) gene maps to a single chromosome site, 3q26
17. Structure of the gene for human butyrylcholinesterase: Evidence for a single copy
18. Proposed nomenclature for human butyrylcholinesterase genetic variants identified by DNA sequencing
19. Dose-response relationship for mivacurium in patients with phenotypically abnormal plasma cholinesterase activity
20. Pharmacokinetics of the three isomers of mivacurium and pharmacodynamics of the chiral mixture in hepatic cirrhosis
21. The influence of drug-induced low plasma cholinesterase activity on the pharmacokinetics and pharmacodynamics of mivacurium
22. Pharmacokinetics and pharmacodynamics of the three isomers of mivacurium in health, in end-stage renal failure and in patients with impaired renal function
23. Identification of a frameshift mutation responsible for the silent phenotype of human serum cholinesterase, Gly 117 (GGT→GGAG)
24. Genetic mutations of butyrylcholine esterase identified from phenotypic abnormalities in Japan
25. Genetic analysis of a Japanese patient with butyrylcholinesterase deficiency
26. Mutations of human butyrylcholinesterase gene in a family with hypocholinesterasemia
27. Nonsense mutation in exon 2 of the butyrylcholinesterase gene: A case of familial cholinesterasemia
28. Inactivation of the cholinesterase gene by Alu insertion: Possible mechanism for human gene transposition
29. Butyrylcholinesterase genes in individuals with abnormal inhibition numbers and with trace activity: One common mutation and two novel silent genes
30. Characterization of 12 silent alleles of the human butyrylcholinesterase (BCHE) gene
31. Plasma cholinesterase variants and the anaesthetist
32. Serum cholinesterase polymorphism in France: An epidemiological survey of the deficient alleles detected by an automated micro-method